Alexion runs toward big Ultomiris goals with early Soliris switching success

Alexion has big goals for Soliris follow-up Ultomiris in paroxysmal nocturnal hemoglobinuria, and wooing patients over from predecessor Soliris is key. But so far, executives say, those aims are right on track.